These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 38857659)
21. Pan-TRK Immunohistochemistry Is Highly Correlated With NTRK3 Gene Rearrangements in Salivary Gland Tumors. Csanyi-Bastien M; Lanic MD; Beaussire L; Ferric S; François A; Meseure D; Jardin F; Wassef M; Ruminy P; Laé M Am J Surg Pathol; 2021 Nov; 45(11):1487-1498. PubMed ID: 33899788 [TBL] [Abstract][Full Text] [Related]
22. NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma. Chiang S; Cotzia P; Hyman DM; Drilon A; Tap WD; Zhang L; Hechtman JF; Frosina D; Jungbluth AA; Murali R; Park KJ; Soslow RA; Oliva E; Iafrate AJ; Benayed R; Ladanyi M; Antonescu CR Am J Surg Pathol; 2018 Jun; 42(6):791-798. PubMed ID: 29553955 [TBL] [Abstract][Full Text] [Related]
23. Clinical and Morphologic Features of ETV6-NTRK3 Translocated Papillary Thyroid Carcinoma in an Adult Population Without Radiation Exposure. Seethala RR; Chiosea SI; Liu CZ; Nikiforova M; Nikiforov YE Am J Surg Pathol; 2017 Apr; 41(4):446-457. PubMed ID: 28125451 [TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic Characteristics of Thyroid Nodules Positive for the Morariu EM; McCoy KL; Chiosea SI; Nikitski AV; Manroa P; Nikiforova MN; Nikiforov YE Thyroid; 2021 Aug; 31(8):1212-1218. PubMed ID: 33487086 [No Abstract] [Full Text] [Related]
25. Pan-tumor screening for NTRK gene fusions using pan-TRK immunohistochemistry and RNA NGS fusion panel testing. Koehne de González A; Mansukhani MM; Fernandes H; Hsiao SJ Cancer Genet; 2022 Apr; 262-263():47-52. PubMed ID: 35007853 [TBL] [Abstract][Full Text] [Related]
26. [Comparison of the methods for detecting NTRK gene fusion variations in papillary thyroid carcinoma]. Jiang YY; Chen H; Xu BL; Wang S Zhonghua Bing Li Xue Za Zhi; 2022 Aug; 51(8):726-732. PubMed ID: 35922162 [No Abstract] [Full Text] [Related]
28. Molecular and Cytogenetic Features of NTRK Fusions Enriched in BRAF and RET Double-Negative Papillary Thyroid Cancer. Wu S; Liu Y; Li K; Liang Z; Zeng X J Mol Diagn; 2023 Aug; 25(8):569-582. PubMed ID: 37236546 [TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics and treatment patterns of patients with Willis C; Au T; Hejazi A; Griswold C; Schabath MB; Thompson J; Malhotra J; Federman N; Ko G; Appukkuttan S; Warnock N; Kong SX; Hocum B; Brixner D; Stenehjem D J Manag Care Spec Pharm; 2024 Jul; 30(7):672-683. PubMed ID: 38950155 [TBL] [Abstract][Full Text] [Related]
30. Diagnosis and Management of Tropomyosin Receptor Kinase Fusion-Positive Thyroid Carcinomas: A Review. Haddad R; Elisei R; Hoff AO; Liu Z; Pitoia F; Pruneri G; Sadow PM; Soares F; Turk A; Williams MD; Wirth LJ; Cabanillas ME JAMA Oncol; 2023 Aug; 9(8):1132-1141. PubMed ID: 37289450 [TBL] [Abstract][Full Text] [Related]
31. NTRK fusions in thyroid cancer: Pathology and clinical aspects. Ma Y; Zhang Q; Zhang K; Liang Y; Ren F; Zhang J; Kan C; Han F; Sun X Crit Rev Oncol Hematol; 2023 Apr; 184():103957. PubMed ID: 36907364 [TBL] [Abstract][Full Text] [Related]
32. NTRK Gene Fusion Detection in Atypical Spitz Tumors. Cappellesso R; Nozzoli F; Zito Marino F; Simi S; Castiglione F; De Giorgi V; Cota C; Senetta R; Scognamiglio G; Anniciello AM; Cesinaro AM; Mandalà M; Gianatti A; Valente MG; Valeri B; Sementa AR; Ricci C; Corti B; Roviello G; Dei Tos AP; Franco R; Massi D Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830218 [TBL] [Abstract][Full Text] [Related]
34. NTRK gene fusions are detected in both secretory and non-secretory breast cancers. Maund SL; Sokol ES; Ang Houle A; Ross JS; Wilson TR Pathol Int; 2022 Mar; 72(3):187-192. PubMed ID: 35102630 [TBL] [Abstract][Full Text] [Related]
35. The oncogenic roles of NTRK fusions and methods of molecular diagnosis. Aref-Eshghi E; Lin F; Li MM; Zhong Y Cancer Genet; 2021 Nov; 258-259():110-119. PubMed ID: 34710798 [TBL] [Abstract][Full Text] [Related]
36. Identifying patients with NTRK fusion cancer. Solomon JP; Benayed R; Hechtman JF; Ladanyi M Ann Oncol; 2019 Nov; 30(Suppl_8):viii16-viii22. PubMed ID: 31738428 [TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic Features and Cytologic Correlation of ALK-Rearranged Papillary Thyroid Carcinoma: A Series of Eight Cases. Shih KP; Lee YC; Tsai JJ; Lin SH; Liu CY; Li WS; Li CF; Hang JF Endocr Pathol; 2024 Jun; 35(2):134-146. PubMed ID: 38642308 [TBL] [Abstract][Full Text] [Related]
38. Identifying patients with NTRK fusion cancer. Solomon JP; Benayed R; Hechtman JF; Ladanyi M Ann Oncol; 2019 Nov; 30 Suppl 8():viii16-viii22. PubMed ID: 32223934 [TBL] [Abstract][Full Text] [Related]
39. NTRK fusions and Trk proteins: what are they and how to test for them. Weiss LM; Funari VA Hum Pathol; 2021 Jun; 112():59-69. PubMed ID: 33794242 [TBL] [Abstract][Full Text] [Related]